Complement Component C1q as Serum Biomarker to Detect Active TuberculosisRosalie Lubbers, Leendert A. Trouw, Annemieke Geluk et al.|Frontiers in Immunology|2018Cited by 68
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trialEsther Wittermans, Stefan M.T. Vestjens, Simone M.C. Spoorenberg et al.|European Respiratory Journal|2021Cited by 56
High‐sensitivity cardiac troponin <scp>T</scp> predicts mortality after hospitalization for community‐acquired pneumoniaStefan M.T. Vestjens, Simone M.C. Spoorenberg, Ger T. Rijkers et al.|Respirology|2017Cited by 51
<scp>YKL</scp>‐40, <scp>CCL18</scp> and <scp>SP‐D</scp> predict mortality in patients hospitalized with community‐acquired pneumoniaSimone M.C. Spoorenberg, Stefan M.T. Vestjens, Ger T. Rijkers et al.|Respirology|2016Cited by 38
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patientsRosalie Lubbers, Leendert A. Trouw, Jayne S. Sutherland et al.|Molecular Immunology|2020Cited by 33